LUCID GROUP INC (LCID)

US5494981039 - Common Stock

2.675  -0.08 (-3.08%)

Fundamental Rating

2

Overall LCID gets a fundamental rating of 2 out of 10. We evaluated LCID against 42 industry peers in the Automobiles industry. LCID scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. LCID is valied quite expensively at the moment, while it does show a decent growth rate.



0

1. Profitability

1.1 Basic Checks

LCID had negative earnings in the past year.
LCID had a negative operating cash flow in the past year.
In the past 5 years LCID always reported negative net income.
LCID had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -36.26%, LCID is doing worse than 66.67% of the companies in the same industry.
LCID has a Return On Equity of -82.23%. This is in the lower half of the industry: LCID underperforms 61.90% of its industry peers.
Industry RankSector Rank
ROA -36.26%
ROE -82.23%
ROIC N/A
ROA(3y)-41.98%
ROA(5y)-44.54%
ROE(3y)-79.52%
ROE(5y)-71.61%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for LCID so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

4

2. Health

2.1 Basic Checks

LCID does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, LCID has more shares outstanding
The debt/assets ratio for LCID has been reduced compared to a year ago.

2.2 Solvency

LCID has an Altman-Z score of -1.66. This is a bad value and indicates that LCID is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -1.66, LCID perfoms like the industry average, outperforming 40.48% of the companies in the same industry.
A Debt/Equity ratio of 0.57 indicates that LCID is somewhat dependend on debt financing.
LCID has a Debt to Equity ratio (0.57) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF N/A
Altman-Z -1.66
ROIC/WACCN/A
WACC10.29%

2.3 Liquidity

LCID has a Current Ratio of 3.71. This indicates that LCID is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.71, LCID belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
LCID has a Quick Ratio of 3.26. This indicates that LCID is financially healthy and has no problem in meeting its short term obligations.
LCID's Quick ratio of 3.26 is amongst the best of the industry. LCID outperforms 92.86% of its industry peers.
Industry RankSector Rank
Current Ratio 3.71
Quick Ratio 3.26

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 24.52% over the past year.
Looking at the last year, LCID shows a small growth in Revenue. The Revenue has grown by 4.98% in the last year.
The Revenue has been growing by 430.99% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)24.52%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%9.68%
Revenue 1Y (TTM)4.98%
Revenue growth 3Y430.99%
Revenue growth 5YN/A
Sales Q2Q%45.15%

3.2 Future

LCID is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.73% yearly.
LCID is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 62.30% yearly.
EPS Next Y18.83%
EPS Next 2Y14.92%
EPS Next 3Y12.54%
EPS Next 5Y12.73%
Revenue Next Year23.9%
Revenue Next 2Y51.35%
Revenue Next 3Y69.14%
Revenue Next 5Y62.3%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for LCID. In the last year negative earnings were reported.
Also next year LCID is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as LCID's earnings are expected to grow with 12.54% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y14.92%
EPS Next 3Y12.54%

0

5. Dividend

5.1 Amount

LCID does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

LUCID GROUP INC

NASDAQ:LCID (12/18/2024, 10:06:09 AM)

2.675

-0.08 (-3.08%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap8.06B
Analysts
Price Target
Short Float %
Short Ratio
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -36.26%
ROE -82.23%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 3.71
Quick Ratio 3.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)24.52%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y18.83%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)4.98%
Revenue growth 3Y430.99%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y